New Zealand markets closed

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.1500-0.2000 (-4.60%)
At close: 04:00PM EDT
4.1501 +0.00 (+0.00%)
After hours: 06:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 339.32M
Enterprise value -2.66M
Trailing P/E 85.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.62
Price/book (mrq)2.27
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 3-29.42%
S&P500 52-week change 326.27%
52-week high 36.1300
52-week low 32.0100
50-day moving average 34.1914
200-day moving average 33.9388

Share statistics

Avg vol (3-month) 3991.87k
Avg vol (10-day) 3662.86k
Shares outstanding 581.76M
Implied shares outstanding 681.76M
Float 849.42M
% held by insiders 10.92%
% held by institutions 174.70%
Shares short (30 Apr 2024) 41.95M
Short ratio (30 Apr 2024) 41.85
Short % of float (30 Apr 2024) 42.40%
Short % of shares outstanding (30 Apr 2024) 42.38%
Shares short (prior month 28 Mar 2024) 42.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -69.47%
Operating margin (ttm)37.94%

Management effectiveness

Return on assets (ttm)-12.71%
Return on equity (ttm)-58.25%

Income statement

Revenue (ttm)153.73M
Revenue per share (ttm)2.56
Quarterly revenue growth (yoy)1,217.40%
Gross profit (ttm)N/A
EBITDA -82.46M
Net income avi to common (ttm)-106.79M
Diluted EPS (ttm)-1.7800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)375.62M
Total cash per share (mrq)6.01
Total debt (mrq)33.63M
Total debt/equity (mrq)22.48%
Current ratio (mrq)4.50
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-111.62M
Levered free cash flow (ttm)-30.58M